Literature DB >> 7333236

Prenatal susceptibility to carcinogenesis by xenobiotic substances including vinyl chloride.

J M Rice.   

Abstract

The carcinogenicity of vinyl chloride for experimental animals when administered transplacentally is reviewed in comparison with known transplacental carcinogens, including those that, like vinyl chloride, are dependent on enzyme-mediated metabolic conversion to a reactive intermediate in maternal or fetal tissues. Vinyl chloride is converted by mixed-function oxidases to the reactive metabolite chlorooxirane, the carcinogenicity of which is also reviewed. Vinyl chloride is unequivocally a transplacental carcinogen for the rat. No evidence exists, however, to support the hypothesis that exposure of male rats to vinyl chloride or any other carcinogen confers an increased risk of tumor development on their progeny. Many structural analogs of vinyl chloride, i.e., substituted ethylenes, are also carcinogenic for adult animals, and can with confidence likewise be predicted to be effective transplacental carcinogens.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7333236      PMCID: PMC1568855          DOI: 10.1289/ehp.8141179

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  15 in total

1.  Occupational carcinogenesis. Predictive value of carcinogenesis bioassays.

Authors:  C Maltoni
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

2.  Mutagenic and alkylating metabolites of halo-ethylenes, chlorobutadienes and dichlorobutenes produced by rodent or human liver tissues. Evidence for oxirane formation by P450-linked microsomal mono-oxygenases.

Authors:  H Bartsch; C Malaveille; A Barbin; G Planche
Journal:  Arch Toxicol       Date:  1979-02-23       Impact factor: 5.153

Review 3.  The resolution and reconstitution of the liver microsomal hydroxylation system.

Authors:  A Y Lu; W Levin
Journal:  Biochim Biophys Acta       Date:  1974-09-16

4.  [Transplacental induction of malignant tumors of the nervous system. I. Ethyl-nitroso-urea (ENU) in BD IX rats].

Authors:  S Ivankovic; H Druckrey
Journal:  Z Krebsforsch       Date:  1968

5.  Blastomogenic effect of dimethylnitrosamine on pregnant rats and their offspring.

Authors:  V A Alexandrov
Journal:  Nature       Date:  1968-04-20       Impact factor: 49.962

6.  Cytochrome P-450 and the metabolism of vinyl chloride.

Authors:  A G Salmon
Journal:  Cancer Lett       Date:  1976-11       Impact factor: 8.679

7.  Diaplacental carcinogenesis: initiation with the carcinogens dimethylbenzanthracene (DMBA) and urethane during fetal life and postnatal promotion with the phorbol ester TPA in a modified 2-stage Berenblum/Mottram experiment.

Authors:  K Goerttler; H Loehrke
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1976-11-22

8.  Prenatal multicarcinogenesis by ethylnitrosourea in mice.

Authors:  S D Vesselinovitch; M Koka; K V Rao; N Mihailovich; J M Rice
Journal:  Cancer Res       Date:  1977-06       Impact factor: 12.701

9.  Carcinogenesis: a late effect of irreversible toxic damage during development.

Authors:  J M Rice
Journal:  Environ Health Perspect       Date:  1976-12       Impact factor: 9.031

10.  Haloethylene-related compounds of industrial, environmental, and medical significance.

Authors:  H S Posner; H L Falk
Journal:  Environ Health Perspect       Date:  1977-12       Impact factor: 9.031

View more
  2 in total

1.  Comparison of carcinogenic potency across life stages: implications for the assessment of transplacental cancer risk.

Authors:  R Dzubow; C Fields; G Ginsberg; M Sandy; M Mabson; B Foos
Journal:  J Toxicol Environ Health A       Date:  2019-08-11

2.  Aflatoxin B1-DNA adduct formation and mutagenicity in livers of neonatal male and female B6C3F1 mice.

Authors:  Leslie L Woo; Patricia A Egner; Crystal L Belanger; Roongtiwa Wattanawaraporn; Laura J Trudel; Robert G Croy; John D Groopman; John M Essigmann; Gerald N Wogan; Jason T Bouhenguel
Journal:  Toxicol Sci       Date:  2011-04-19       Impact factor: 4.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.